Literature DB >> 7704840

Alterations in clinical, hematological and metabolic variables in bovine neonatal endotoxemia.

T C Gerros1, S D Semrad, R A Proctor.   

Abstract

Endotoxemia is an important cause of morbidity and mortality in the neonate. Although many models are used to study the problem, none completely simulates the natural disease. To more clearly define a bovine neonatal endotoxemia model we studied the effects of dose of endotoxin on clinical, hematological and biochemical variables. Thirty-four neonatal calves were administered Escherichia coli endotoxin (LPS) at 0 (0.9% saline solution), 0.2, 2.0 or 20 micrograms/kg, by either IV bolus or infusion over 50 minutes. Variables monitored included mean arterial blood pressure (MAP), leukocyte (WBC) count, plasma glucose and lactate concentrations and clinical status. All LPS-treated calves displayed similar clinical signs within one hour. Dose-dependent differences in response to LPS among groups became evident over time. Substantial dose-dependent changes in attitude, appetite, mucous membrane character, capillary refill time, MAP, plasma glucose and lactate concentrations, and WBC count were noted in LPS-treated calves. Higher doses of LPS induced a more prolonged clinical response and significantly (p < 0.05) greater hypotension, lacticemia and hypoglycemia. While dose altered the response to endotoxin, the method of administration had no overall effect on the variables measured.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7704840      PMCID: PMC1263731     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  21 in total

1.  Management of salmonellosis in neonatal calves.

Authors:  H E Amstutz
Journal:  J Am Vet Med Assoc       Date:  1978-09-01       Impact factor: 1.936

Review 2.  ESCHERICHIA COLI AND NEONATAL DISEASE OF CALVES.

Authors:  C C GAY
Journal:  Bacteriol Rev       Date:  1965-03

3.  Endotoxin shock in calves from intravenous injection of rumen bacterial endotoxin.

Authors:  T G Nagaraja; E E Bartley; H D Anthony; H W Leipold; L R Fina
Journal:  J Anim Sci       Date:  1979-08       Impact factor: 3.159

4.  The effects of Escherichia coli endotoxin in calves.

Authors:  C Wray; J R Thomlinson
Journal:  Res Vet Sci       Date:  1972-11       Impact factor: 2.534

5.  Physiologic and metabolic factors in the pathogenesis of neonatal enteric infections in calves.

Authors:  B Tennant; D Harrold; M Reina-Guerra
Journal:  J Am Vet Med Assoc       Date:  1972-11-01       Impact factor: 1.936

6.  Escherichia coli endotoxemia in conscious calves.

Authors:  W O Reece; J D Wahlstrom
Journal:  Am J Vet Res       Date:  1973-06       Impact factor: 1.156

7.  Comparative studies on the toxicity of Escherichia coli lipopolysaccharide endotoxin in various animal species.

Authors:  I Berczi; L Bertók; T Bereznai
Journal:  Can J Microbiol       Date:  1966-10       Impact factor: 2.419

8.  Phases of glucose dyshomeostasis in endotoxicosis.

Authors:  J P Filkins
Journal:  Circ Shock       Date:  1978

9.  Clinical and clinico-pathological effects of Escherichia coli endotoxin in mature cattle.

Authors:  L C Griel; A Zarkower; R J Eberhart
Journal:  Can J Comp Med       Date:  1975-01

10.  Bovine salmonellosis: experimental production and characterization of the disease in calves, using oral challenge with Salmonella typhimurium.

Authors:  B P Smith; F Habasha; M Reina-Guerra; A J Hardy
Journal:  Am J Vet Res       Date:  1979-11       Impact factor: 1.156

View more
  2 in total

1.  Cardiac isoenzymes in healthy Holstein calves and calves with experimentally induced endotoxemia.

Authors:  Simon F Peek; Fred S Apple; Mary Ann Murakami; Peter M Crump; Susan D Semrad
Journal:  Can J Vet Res       Date:  2008-07       Impact factor: 1.310

Review 2.  Review: Utilization of yeast of Saccharomyces cerevisiae origin in artificially raised calves.

Authors:  Gibson M Alugongo; Jianxin Xiao; Zhaohai Wu; Shengli Li; Yajing Wang; Zhijun Cao
Journal:  J Anim Sci Biotechnol       Date:  2017-05-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.